Toumai telesurgery system receives NMPA commercial approval
China's National Medical Products Administration approved the Toumai tele-robotic surgical system for commercial clinical use.
Evidence notes
- The approval covered MicroPort MedBot's next-generation tele-surgical platform for operation across complex network environments.
- Toumai supports 5G, broadband, dedicated-fiber and satellite connections for one-to-many and many-to-many surgical links.
- The network had supported nearly 400 tele-surgical procedures and extended across six continents.
Company context
MicroPort MedBot is a Shanghai surgical-robotics company developing laparoscopic, orthopaedic, vascular-interventional and other robot-assisted procedure systems.